Generex Biotechnology Expands Medical Device Portfolio With Acquisition of Olaregen Therapeutix Inc.
Announces Commercial Launch of FDA Approved Excellagen®, Proprietary, Patented Wound Care Product Focused on the Treatment of Complicated Wounds including Diabetic Ulcers and 16 Other FDA Approved Indications
MIRAMAR, Florida, November 28, 2018 -- (... Devices, Wound Care, Mergers & Acquisitions Generex Biotechnology, Olaregen Therapeutix, Excellagen, flowable dermal matrix
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Dermatology | Diabetes | Diabetic Ulcers | Endocrinology | Medical Devices | Mergers and Aquisitions | Pharmaceuticals